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A system of self-sustained biological clocks controls the 24-h rhythms of behavioral and physiological
processes such as the sleep–wake cycle. The circadian clock system is regulated by transcriptional and
translational negative feedback loops of multiple clock genes. Polymorphisms in circadian clock genes have
been associated with morningness–eveningness (diurnal) preference, familial advanced sleep phase type
(ASPT), and delayed sleep phase type (DSPT). We genotyped single-nucleotide polymorphisms in circadian
clock genes in 182 DSPT individuals, 67 free-running type (FRT) individuals, and 925 controls. The clock
gene polymorphisms were tested for associations with diurnal preference and circadian rhythm sleep
disorder (CRSD) phenotypes. The PER3 polymorphism (rs228697) was significantly associated with diurnal
preference and the FRT phenotype. The minor allele of rs228697 was more prevalent in evening types than
in morning types (sex-adjusted odds ratio (OR), 2.483, Bonferroni-corrected P 5 0.012) and in FRT
individuals compared with the controls (age- and sex-adjusted OR, 2.021, permutated P 5 0.017). Our
findings support the notion that PER3 polymorphisms could be a potential genetic marker for an
individual’s circadian and sleep phenotypes.
S
leep–wake cycles are regulated by two components, homeostatic drive and circadian drive1. Sleep and
wakefulness occur sequentially, and sleep propensity increases gradually with extended wakefulness and
decreases rapidly during sleep. Sleep propensity is under the control of sleep homeostasis, and sleep timing
is under the control of circadian clocks. The circadian clock system regulates daily behavioral and physiological
rhythms such as body temperature, hormone secretion, blood pressure, metabolism, and cognitive performance
besides sleep/wakefulness. These rhythms are generated by the central circadian oscillator located in the supra-
chiasmatic nucleus (SCN) of the hypothalamus and are entrained by environmental cues (e.g., light–dark
cycles)2,3. The molecular mechanism of the circadian clock system involves transcription-translation negative
feedback loops of multiple clock genes and post-transcriptional and post-translational modification and degra-
dation of clock proteins4,5. The transcription factors BMAL1 and CLOCK form heterodimers, which activate
transcription of Cryptochrome (Cry) and Period (Per) by binding to E-box motifs in their promoter regions. CRY
and PER proteins gradually accumulate in the cytoplasm. Phosphorylation of CRY and PER is regulated by casein
kinase I (CKI). CRY, PER, and CKI proteins form complexes that translocate to the nucleus and interact with the
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function of Timeless (Tim) remains to be determined, Tim is known
to modulate neuronal firing rhythms in the SCN6.
Circadian rhythm sleep disorders (CRSDs) are defined by persist-
ent or recurrent disturbed sleep–wake cycles and comprise several
subtypes: advanced sleep phase type (ASPT), delayed sleep phase
type (DSPT), and free-running type (FRT). ASPT is characterized
by extremely early involuntary sleep timing, DSPT by significantly
delayed sleep timing, and FRT by sleep timing that occurs with a 30-
min to 1-h delay each day. CRSD is thought to result from impair-
ment of the circadian clock system7–9. Also, circadian characteristics
vary greatly among individuals10,11. The inter-individual differences
in daily activity/sleep time are known as morningness–eveningness
(diurnal) preference. The morning type manifests earlier timings for
sleep and physiological rhythms than the intermediate type, and still
earlier than the evening type12,13. Individual diurnal preference is
morning type during childhood, which subsequently switches to
evening type during adolescence before starting to return to morning
type in adulthood14,15. Males show evening preference while females
show more morning preference, but this gender-related difference
disappears in the elderly11,16. The diurnal preference is commonly
assessed by self-reported questionnaires, the Horne–Östberg
Morningness–Eveningness Questionnaire (MEQ)10 and the recently
developed Munich ChronoType Questionnaire (MCTQ)11. The
diurnal preference and CRSD phenotypes are thought to be influ-
enced by genetic factors. For example, polymorphisms in the
CLOCK, NPAS2, PER2, and TIM genes are associated with diurnal
preference17,18, sleep timing19, and sleep disorders20–22. Furthermore,
the PER3 gene has polymorphisms in the promoter region23, mis-
sense polymorphisms that result in amino acid substitution and a
variable number tandem repeat (VNTR) consisting of either 4 or 5
repeated 54-bp sequences encoding 18 amino acids (PER34 or
PER35)24. These PER3 polymorphisms are associated with diurnal
preference and/or DSPT23–25. Although the results of some other
studies are inconsistent with the associations26,27, a number of genetic
studies have shown that genetic factors significantly contribute to
individual differences in circadian and sleep phenotypes28–30.
Missense mutations in the PER2 and CKId genes have been found
in large pedigrees with familial ASPT31,32. These amino acid substitu-
tions in PER2 and CKId reduce the phosphorylation level of PER2,
thereby shortening the intrinsic circadian period (t) and giving rise
to the familial ASPT phenotype. These findings indicate that clock
gene polymorphisms, especially missense polymorphisms, may alter
the function of these genes, thereby modifying diurnal preference
and sleep–wake patterns. To investigate how genetic variations im-
pact circadian and sleep phenotypes, we genotyped single-nucleotide
polymorphisms (SNPs) in a number of circadian clock genes in
controls and DSPT and FRT patients and tested these SNPs for
associations with diurnal preference in controls and in patients with
the CRSD phenotype. Our control subjects’ diurnal preference was
assessed by the Horne–Östberg MEQ10. Age-adjusted MEQ scores of
16–41 denote evening types, 42–58 denote intermediate types, and
59–86 denote morning types. The DSPT and FRT patients were
diagnosed according to the International Classification of Sleep
Disorders 2 (ICSD-2)33.
Results
Association between PER3 and diurnal preference. The 925
controls consisted of 245 morning types (79 men and 166 women;
mean 6 SD age-adjusted MEQ score: 62.81 6 3.77), 594
intermediate types (163 men and 431 women; mean 6 SD age-
adjusted MEQ score: 51.13 6 4.31), and 86 evening types (32 men
and 54 women; mean 6 SD age-adjusted MEQ score: 38.23 6 3.55).
Men showed more evening preference than women (x2 5 9.077, P 5
0.011; adjusted residual 5 62.3). The allele frequency of the 9 SNPs
in 6 genes was compared among morning, intermediate, and evening
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was significantly associated with diurnal preference (x2 5 9.157, P 5
0.010). The major allele C of rs228697 was more common in
morning types than in evening types, and the minor allele G of
rs228697 was more common in evening types than in morning
types (sex-adjusted odds ratio (OR), 2.483; 95% confidence interval
(CI), 1.339–4.603; Bonferroni-corrected P 5 0.012; crude P 5 0.004).
Subjects with the G-positive genotype (CG, GG) for rs228697
showed lower age-adjusted MEQ scores than those with the G-
negative genotype (CC) for rs228697 (mean 6 SEM age-adjusted
MEQ score: 51.70 6 0.68 vs 53.26 6 0.29; F(1, 922) 5 4.561; P 5
0.033).
Association between PER3 and FRT. We then assessed the proba-
bility of the 9 SNPs producing DSPT and FRT phenotypes (Table 2).
The SNP distributions did not differ between the controls and DSPT
individuals. However, the rs228697 distribution significantly differed
between controls and FRT individuals. The frequency of the G allele
for rs228697 was significantly increased in FRT individuals com-
pared with controls (age- and sex-adjusted OR, 2.021; 95% CI,
1.160–3.524; permutated P 5 0.017; crude P 5 0.011). The G-
positive genotype (CG, GG) for rs228697 was more prevalent in
FRT individuals (CG, GG, 0.284) than in controls (CG, GG, 0.154)
with an age- and sex-adjusted OR of 2.253 (95% CI, 1.233–4.118; P 5
0.008). Therefore, the PER3 SNP rs228697 was significantly
associated with the FRT phenotype in this cohort.
Discussion
We found that the G allele of rs228697 in PER3 was more common in
evening types than in morning types and in FRT individuals than in
controls using a very large sample of control individuals and CRSD
patients. These findings are in accordance with previous reports23–25
suggesting genetic associations between PER3 polymorphisms and
diurnal preference and/or CRSD phenotypes. A PER3 haplotype
defined by the G allele of rs10462020 and the C allele of
rs10462021 has been shown to be related to DSPT24. Furthermore,
the 4-repeat allele of PER3 VNTR (PER34) has been associated with
extreme evening preference and DSPT, whereas the 5-repeat allele of
PER3 VNTR (PER35) has been associated with extreme morning
preference25. In addition, the polymorphisms in the PER3 promoter
have been associated with DSPT23. Although the SNPs rs10462020
and rs10462021 were excluded from further analysis due to the low
minor allele frequency (MAF) , 0.05, and the PER34 and PER35
alleles as well as the previously described polymorphisms in the
PER3 promoter, were not directly investigated in this study, the
present and previous findings strongly suggest that PER3 poly-
morphisms can provide potential biomarkers for estimating indi-
vidual diurnal preference and CRSD phenotypes.
Morning types and evening types have been reported to differ in
homeostatic sleep regulation and neurobehavioral functions in res-
ponse to sleep fragmentation and sleep deprivation29. Mongrain et al.
have demonstrated that the morning type exhibits a higher initial
level and faster dissipation rate of sleep pressure than the evening
type34. These results suggest that diurnal preference may reflect indi-
vidual differences in both homeostatic and circadian regulation.
Moreover, there are inter-individual differences in the impairment
of neurobehavioral functions (attention, decision making, etc.) in
response to sleep deprivation and sleep restriction35–37. A number
of studies indicate that genetic traits contribute to individual differ-
ences in sleep homeostasis, circadian rhythms, and cognitive per-
formance28,38. Individuals homozygous for PER35 demonstrate more
morning preference, greater sleep propensity at baseline and after
sleep deprivation, and a lower level of cognitive performance than
those homozygous for PER34 39,40. The results of our previous study
have implied that an altered expression profile of PER3 may reflect
deteriorated homeostatic sleep drive in the elderly41. Additionally,
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promoter are associated with DSPT and that these polymorphisms
have an effect on its expression level23. The data reported here
showed that the PER3 SNP rs228697 was associated with diurnal
preference and FRT phenotype in our large sample of CRSD patients
and controls. These findings suggest that the PER3 gene may play a
functional role in homeostatic sleep and/or circadian clock systems.
Furthermore, PER3 polymorphisms may predict individual differ-
ences in vulnerability to sleep deprivation and restriction.
The SNP rs228697 (C/G) corresponds to the SNP in exon 17 of the
PER3 gene and causes the amino acid substitution (P864A)24.
Although the amino acid substitution of proline (P) to alanine (A)
does not make a significant difference to polarity or hydrophobicity,
the amino acids P and A differ in their hydropathy index.
Accordingly, the P/A substitution could alter the secondary structure
and/or phosphorylation status of PER3 leading to dysregulation of
the homeostatic sleep and circadian clock systems. It is intriguing
that P864A is located in potential Src homology (SH)3 domains in
PER3. SH3 domains are found in many proteins in an array of
signaling pathways that regulate the cytoskeleton, the Ras gene
family, and the Src kinase family, as well as many other signaling
cascades42,43. The proline-rich motif X-P-X-X-P is defined as the
minimal consensus sequence of the SH3-binding sites. X is often
an aliphatic amino acid44. The P864A substitution would disrupt
two potential SH3-binding motif domains in PER3 (LPDPP(864)
and PP(864)VCP), which could alter the binding interaction between
PER3 and its partner protein(s), thereby disturbing the function of
PER3 in the homeostatic and circadian regulation of sleep. CKI
interacts with the scaffolding protein NCK that consists of SH2
and SH3 domains45. As CKI is known to regulate PER protein
stability46,47, it is interesting to speculate that the interaction between
CKI and PER3 may be partially mediated via the scaffolding afforded
by the interactions between the SH3 domain in NCK and the putative
SH3 ligand in PER3. However, how this allelic variation of PER3
modifies sleep and circadian phenotypes remains to be determined.
FRT is defined by sleep timing that occurs with a 30-min to 1-h
delay each day. Therefore, prolongation of t has been considered a
critical factor for determining the FRT phenotype7–9. Free-running
patterns in sleep–wake cycles are often observed in blind indivi-
duals48. Because totally blind individuals are not capable of perceiv-
ing photic signals, some may show free-running sleep patterns as a
consequence of the loss of photic entrainment. Thus, the patho-
physiology of sighted individuals with FRT might also be associated
with an impaired photic entrainment mechanism as well as with
prolonged t. We recently reported that sighted FRT patients have
a longer t than intermediate types, but not when compared with
evening types49. Moreover, the results of the present study dem-
onstrate that extreme evening preference and FRT are associated
with the same polymorphism in the PER3 gene. Based upon these
findings, there may be a genetic trait or traits shared by individuals
with extreme evening preference and FRT phenotypes. In contrast,
DSPT was not associated with any polymorphisms in the PER3 gene
or other clock genes investigated in this study. It appears likely that
this results from the heterogeneity of the DSPT population. Not only
circadian clock defects, but also psychiatric problems and/or con-
sequent reduction of social (non-photic) entrainment are thought to
be causative factors for the development of DSPT phenotypes50.
There are some limitations to this study. It would be difficult to
conduct a replication study using another sample of patients due to
the extremely low prevalence of CRSDs in the Japanese population
(0.13%)51. Other groups have shown associations of PER3 and
diurnal preference and/or CRSD phenotypes using their samples23–25.
We did not control for medical treatments in our subjects, such as
medication and light therapy, although these treatments would only
alter the medical condition of patients and not their diagnoses.
Table 3 | Genotype and minor allele frequencies of 30 SNPs in 7 genes in 925 controls
Gene SNP Allele (A/a) Variation (amino acid) AA Aa aa MAF P (HWE) Genotyping Assay ID
CLOCK rs34897046 C/G S/C 1 0 0 0 1 C__25595098_10
rs6855837 C/A L/I 1 0 0 0 1 C__29101689_10
rs3762836 A/G H/R 0.981 0.019 0 0.01 1 C__27479322_10
rs1801260 T/C 0.707 0.268 0.025 0.159 1 C___8746719_20
CRY2 rs2863712 T/G W/G 1 0 0 0 1 C__16079564_10
NPAS2 rs34628006 A/G T/A 1 0 0 0 1 C__25757964_10
rs2305160 G/A A/T 0.659 0.297 0.043 0.192 0.243 C__15976652_10
rs11541353 C/T S/L 1 0 0 0 1 C___2153849_10
rs58728948 G/A A/T 1 0 0 0 1 C__25757546_10
PER1 rs2585405 C/G P/A 0.345 0.477 0.178 0.417 0.592 C__16260899_10
rs3027193 G/A R/H 1 0 0 0 1 C__15770159_10
PER2 rs2304672 C/G 0.893 0.106 0.001 0.054 0.472 C___2129919_1_
rs35572922 G/T A/S 1 0 0 0 1 C__25973284_20
rs4429421 G/A V/I 0.991 0.009 0 0.004 1 C__27970170_10
rs35333999 G/A V/I 1 0 0 0 1 C__25992030_10
rs35998480 T/A F/Y 1 0 0 0 1 C__25958587_10
rs934945 G/A G/E 0.476 0.428 0.096 0.31 1 C___8740718_20
PER3 rs10462020 T/G V/G 0.928 0.07 0.002 0.037 0.731 C__25956444_10
rs35687686 C/T R/W 1 0 0 0 1 C__25970031_10
rs228696 C/T L/P 1 0 0 0 1 C_____10225_10
rs35899625 T/G L/W 1 0 0 0 1 C__25967284_10
rs228697 C/G P/A 0.846 0.149 0.004 0.079 0.606 C_____10224_10
rs2640909 T/C M/T 0.782 0.204 0.014 0.116 0.96
rs2640905 C/G S/C 1 0 0 0 1 C__16268919_10
rs35802556 C/T T/I 1 0 0 0 1
rs10462021 A/G H/R 0.928 0.07 0.002 0.037 0.731
rs35072750 A/G T/A 1 0 0 0 1 C__25963142_20
TIM rs774027 T/A L/I 0.359 0.453 0.188 0.415 0.048 C___8340562_10
rs774047 A/G Q/R 0.354 0.456 0.19 0.418 0.064 C___3134218_10
rs2291739 C/T P/L 0.316 0.474 0.211 0.448 0.215 C__15966257_10
A, major allele; a, minor allele; MAF, minor allele frequency; HWE, Hardy-Weinberg equilibrium; P, P value for HWE.
www.nature.com/scientificreports
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In conclusion, our findings corroborate the involvement of PER3
in regulating the homeostatic sleep and/or circadian systems. The
PER3 gene has the potential to serve as a biomarker for evaluating
genetic traits of sleep and circadian phenotypes and as a research
target to understand the mechanism underling the pathophysiology
of FRT. Life styles have dramatically changed during the past cen-
tury. Shift work and jet lag induce acute sleep deprivation and
chronic sleep restriction, which is associated with deteriorated neu-
robehavioral performance35,52. Furthermore, a misalignment between
endogenous circadian rhythms and sleep–wake cycles known as
internal desynchronization is thought to cause sleep shortage and
circadian rhythm disturbance, leading to elevated risks for auto-
nomic disorders, cardiovascular diseases, metabolic diseases, and
mood disorders53–55. Therefore, predicting sleep and circadian phe-
notypes may help develop interventions to improve quality of life
and potentially prevent various diseases.
Methods
Subjects. The study population consisted of 182 DSPT individuals (111 men and 71
women; mean 6 SD age: 26.68 6 9.25 years), 67 FRT individuals (48 men and 19
women; mean 6 SD age: 26.72 6 9.79 years), and 925 controls (274 men and 651
women; mean 6 SD age: 36.45 6 12.10 years). Patient subjects and controls were all
unrelated, sighted Japanese men and women who were recruited at medical and
research institutes on mainland Japan. None of the controls had a history of sleep
disorders or psychosis. The DSPT and FRT patients were diagnosed by trained
psychiatrists according to the International Classification of Sleep Disorders II
(ICSD-II, 1990, 1997)33. The diagnostic criteria for DSPT are (1) inability to fall asleep
and wake up spontaneously at the desired time; (2) persistent delayed phase of the
major sleep episode in relation to the desired time for sleep; (3) symptoms present for
at least 1 month; and (4) sleep of normal quality and duration when not required to
maintain a conventional sleep–wake schedule. The criteria for FRT are (1) insomnia
or excessive sleepiness related to misalignment between the endogenous circadian
rhythm and the 24-h light–dark cycle; (2) chronic sleep–wake cycle with a longer
period than 24 h; and (3) symptoms present for at least 1 month. Ten DSPT patients
had comorbidities as follows: bipolar, one; major depression, three; pervasive
developmental disorder, two; seasonal affective disorder, two; sleep apnea syndrome,
two. Seventeen FRT patients had comorbidities as follows: bipolar, one; major
depression, one; seasonal affective disorder, one. The protocol was approved by the
respective institutional ethical review boards. All subjects provided written informed
consents. The present study was conducted according to the principles of the
Declaration of Helsinki.
Markers and genotyping. A total of 30 SNPs in 7 genes, CLOCK, CRY2, NPAS2,
PER1, PER2, PER3, and TIM, were selected (Table 3). These genes have been
previously validated in some populations (http://www.ncbi.nlm.nih.gov/snp/).
Overall, 28 SNPs resulted in amino acid substitutions, and 2 SNPs, rs1801260 and
rs2304672, were in the 59 UTR of CLOCK and PER2, respectively. The SNP rs1801260
was associated with evening preference in a Japanese population18 and rs2304672 was
found in a Japanese pedigree of familial ASPT21. Thirty SNPs including rs1801260
and rs2304672 were genotyped in 925 Japanese controls. The Hardy–Weinberg
equilibrium (HWE) was tested for each marker. The SNPs showing monomorphism
with low frequency (MAF , 0.05) or not in HWE (P , 0.05) were excluded from
further analysis. Therefore, 9 SNPs in 6 genes, CLOCK, NPAS2, PER1, PER2, PER3,
and TIM, were genotyped in 249 CRSD individuals.
Blood samples were collected from all subjects and used for DNA isolation.
Genomic DNA was extracted from leukocytes with the QIAamp DNA Blood Midi Kit
(QIAGEN K.K., Tokyo, Japan). Genotyping was performed by a TaqMan SNP
Genotyping assay (Applied Biosystems, Foster City, CA) according to the manufac-
turer’s instructions. The genotyping assay IDs for 27 SNPs are listed in Table 3 and the
primers and TaqMan probes for rs2640909, rs35802556, and rs10462021 are listed in
Table 4.
Self-assessment. The Japanese version of the Horne–Östberg MEQ10 was
administered to assess subjects’ diurnal preference; this tool has been validated in a
Japanese population56. Because diurnal preference changes with age, MEQ scores
were adjusted by age (age-adjusted MEQ score, MEQ score 1 0.3512 3 (39.212 2
age))57. Age-adjusted MEQ scores of 16–41 denote evening types, 42–58 denote
intermediate types, and 59–86 denote morning types. Thus, lower MEQ scores
indicate evening preference.
Statistical analysis. HWE was estimated using Haploview 4.1 (http://www.broad.mit.
edu/mpg/haploview/)58. The chi-squared test was performed to compare the allele
frequency and genotype distribution for each SNP marker among diurnal preference
groups (morning, intermediate, and evening types). The sex-adjusted ORs and 95%
CIs with Bonferroni correction were calculated to evaluate the rs228697 frequency
across the three diurnal preference groups. One-way analysis of variance adjusted for
sex was performed to compare age-adjusted MEQ scores between subjects with
genotype CG or GG for rs228697 and those with genotype CC for rs228697. The chi-
squared and permutation tests (N 5 10,000) were performed to evaluate the
difference in allele frequency between patients (DSPT or FRT) and controls using
Haploview 4.1. The age- and sex-adjusted ORs and 95% CIs were calculated to
evaluate the rs228697 frequency between FRT patients and controls. P , 0.05 was
considered to be statistically significant. Statistical analysis was performed using SPSS
ver.11.5.1J (SPSS Japan Inc., Tokyo, Japan), unless otherwise stated.
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